Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
Quick Find - Click to open on a page
HomeAbout MerckProductsNewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals
Contact Contact Investor Relations
E-mail alerts Sign up for E-mail Alerts
PODCAST Investor Relations Podcast
  RSS RSS

Investor Relations

Welcome to the Merck Investor Center
This site is designed to provide analysts and investors (institutional or retail) with quick and easy access to reliable, accurate and current information about Merck. Here you will find information on; historical company earnings, webcasts, presentations, transcripts, SEC filings, stock information and partnership information. For additional information, please visit About Merck.

News
01/05/2009 Merck to Hold Fourth-Quarter 2008 Sales and Earnings Conference Call on Feb. 3
12/18/2008 Merck & Co., Inc. Awards More Than $8 Million to Non-Profit Organizations in 2008 to Help Address HIV and AIDS Worldwide
12/12/2008 Merck Announces FDA Acceptance of Supplemental New Drug Application for ISENTRESS® (raltegravir) in Adult Patients Previously Untreated for HIV-1
Acrobat PDF file Full Prescribing Information Acrobat PDF file Patient Product Information
12/09/2008 Merck Outlines Long-Term Prospects and Progress on Strategic Plan at 2008 Annual Business Briefing
Printer Friendly Page
 

Stock Quote

Latest prices for Merck stock Stock quote (opens new window)

VIOXX Withdrawal

Information on the voluntary withdrawal of
VIOXX® (rofecoxib)

2007 Annual Review

2007 Annual Review: Achieving Results. Accelerating Discovery. Regaining Leadership.

Corporate Responsibility

Corporate Responsibility

Read report

Corporate Governance

Focusing on the Company's strategic and operational excellence and on the best interests of our shareholders

Merck Pipeline

A summary of the company's research pipeline
 
Contact Merck Site Map Accessibility Statement Privacy Policy Terms of Use Copyright 1995-2008 Merck & Co., Inc.